Ahmedabad, October 27, 2020: : Cadila Pharma in association with Akshaya Patra foundation continues with the distribution of essential food…
New Delhi, October 10, 2020: Cadila Pharmaceuticals launches Tikacad® in India, an antiplatelet drug-containing Ticagrelor, a P2Y12 platelet inhibitor indicated…
New Delhi, September 18, 2020: Last year Cadila Pharma won the CLO award at TISS and Observenow award for innovative…
Ahmedabad September 18, 2020: Cadila Pharmaceuticals launches Obetocad in India, a generic version of Ocaliva® (Obeticholic Acid) primarily used for…
New Delhi, September 08, 2020: "Digital Transformation in pharmaceuticals is here to stay. Cadila Pharma embarked on this journey a…
Ahmedabad, August 06, 2020: Cadila Pharmaceuticals Limited has announced the launch of NuPTH an Osteoporosis biosimilar of Forteo in India.…
New Delhi, July 12, 2020: Based Cadila Pharmaceuticals Limited recently announced the launch of Esomeprazole tablets for the treatment of…
New Delhi, January 24, 2020: The report titled “Brazil Pharmaceuticals Market Outlook to 2025 - By International and Domestic Companies,…
New Delhi, October 05, 2019: Analysts at Ken Research in their latest publication “Saudi Arabia Cold Chain Market Outlook to…
Cadila Pharmaceuticals recognized as the Authorized Economic Operator (AEO) by the Central Board of Indirect Taxes and Customs. Ahmedabad, July…